AMSBIO is a knowledgeable supplier of products dedicated to exosome research that includes high quality reagents and kits that are quick, affordable and easy to use.
The latest addition to this portfolio is a new range of tools for isolating and purifying overall or specific exosome sub-populations from small volumes of sample in an efficient, faster and cheaper way.
For applications that require total exosome isolation from biological fluids including plasma, serum and urine as well as cell culture media, AMSBIO has launched ExoPure™ Reagent - a fast and convenient one-step method based on chemical precipitation.
AMSBIO's new ExoPure™ Isolation kit offers a fast and convenient method of exosome isolation and purification at high yields from body fluids including Cerebrospinal, Amniotic, Inflammatory, Lymph, Breast milk, Saliva, Gastrointestinal and Broncho alveolar lavage fluids. Using this kit enables researchers to more reliably produce highly pure exosomes compared to using exosome precipitation methods.
ExoPure™ Immunoplates are 96-well microplates, covalently pre-coated with specific exosome-binding antibodies to allow exosome capture and isolation from sources including cell supernatant, human plasma, serum, urine and saliva. These high-performance plates are available in transparent, white and black versions tailored to suit the downstream detection approach employed (colorimetry, luminometry or fluorimetry methods respectively).
AMSBIO new range of ExoPure™ Size Exclusion Columns (SEC) are designed for isolating extracellular vesicles in a fast and easy way. These columns are available in two different sizes of column to enable optimized extracellular vesicle purification from biofluids (plasma, serum, urine) and cell media and for different sample volumes.
Exosomes are small endosome derived lipid nanoparticles, actively secreted by exocytosis in most living cells. Exosomes are today widely accepted as important mediators of cell-cell communication, and are studied for their role in normal biological processes and use as biomarkers for diseases, such as cancer. Exosomes are also demonstrating therapeutic potential as a targeted delivery system, and are attractive starting materials for tissue engineering and regenerative medicine applications.
For further information on the new range of ExoPure™ exosome isolation and purification products please visit https://www.amsbio.com/research-areas/exosomes or contact AMSBIO on+44-1235-828200 / +1-617-945-5033 / email@example.com.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.
AMS Biotechnology (AMSBIO)
184 Milton Park
Oxon OX14 4SE
North American HQ